UCSF, Pfizer Renew Research Collaboration, Citing Progress in Drug Discovery Research
UC San Francisco and Pfizer Inc.’s Centers for Therapeutic Innovation have renewed an agreement to identify and develop biologic compounds against both known and novel targets.